On 24th Nov 2015, Uni-Bio Science acquired exclusive global rights to manufacture and commercialise. Mitiglinide, a new oral antidiabetic agent, from Jiangsu Hansoh Pharmaceutical Co. Ltd. Such could enrich Uni-Bio Science portfolio under strategy for endocrinology.